Science Interest Group on Animal Models – 2nd Meeting (AMR Accelerator Members only)

Online

About ten people attended this second meeting with the Scientific Interest Group (SIG) on animal models. As a follow up from the previous SIG meeting, this event focused on “Data Cataloging of animal infection models.”. The attendees contributed to this first version of the in vivo catalog with information about their resources and infection models […]

2023 Antimicrobial Chemotherapy Conference

Online

Please save the date for the 2023 Antimicrobial Chemotherapy Conference. This free to attend virtual conference is organized by GARDP and BSAC in collaboration with ReACT Africa.

Science Communication Interest Group Meeting on Community Engagement (AMR Accelerator Members only)

Basel Marriott Hotel Messeplatz 25, Basel, Basel, Switzerland

People affected with bacterial infections can be involved in every step of antibiotic drug development. Not only can they be receiving an antibiotic treatment that derives from research results, but they can also be contributing partners of research, and even involved in further research. During this Science Communication Interest Group meeting, we explored community engagement […]

7th AMR Conference

Basel Marriott Hotel Messeplatz 25, Basel, Basel, Switzerland

Please save the date for the upcoming 7th AMR Conference 2023! The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. To stay informed visit the website here.  

UNITE4TB webinar: Expert interview on machine learning and artificial intelligence

Online

The topic of the session was machine learning (ML) and artificial intelligence (AI) and how ML/AI tools are being utilized within the UNITE4TB Consortium to select, test and deliver novel combination TB regimens. Split into two parts, the first 30 minutes of the webinar was led by Dr. Carlos Talavera-López of Helmholtz Munich (co-lead of […]